• Carbenoxolone disodium: No-Paper Lab Guide

  2026-09-30

  Carbenoxolone disodium is a research reagent for perturbing 11β-hydroxysteroid dehydrogenase activity, glucocorticoid access, and gap junction communication in cell, tissue, and biochemical workflows. When directly matched paper evidence is unavailable, use it as a controlled mechanistic tool with vehicle, viability, formulation, and orthogonal pathway controls rather than as a selective in vivo efficacy probe.

• Cell Cycle Assay Kit for CRC Mechanism Studies

  2026-09-30

  Map DNA-content changes, cell-cycle arrest, and presumptive apoptosis in colorectal cancer models with a practical PI/RNase A workflow. The approach translates CGF-driven metabolic stress into measurable cell-cycle endpoints while highlighting where orthogonal assays are still required.

• DiscoveryProbe Natural Product Library Plus Workflow

  2026-09-29

  Build an enzyme-to-cell screening cascade around the DiscoveryProbe Natural Product Library Plus, using pre-dissolved compounds to move efficiently from biochemical hit finding to phenotype confirmation. The workflow adapts lessons from Cryptosporidium parvum AdhE research while emphasizing controls, orthogonal validation, and practical troubleshooting.

• Minocycline HCl: Mechanism and EV Research

  2026-09-29

  Minocycline HCl is a semisynthetic tetracycline derivative that inhibits bacterial protein synthesis and also serves as an anti-inflammatory research tool. Its use in extracellular-vesicle workflows should be treated as a controlled mechanistic perturbation, because the cited iMSC-EV manufacturing study did not test minocycline as a process component.

• Amorolfine Hydrochloride in Yeast Integrity Assays

  2026-09-28

  Use Amorolfine Hydrochloride as a controlled membrane-synthesis stressor to connect fungal cell integrity, growth, and ploidy in budding yeast. This guide provides an assay-ready workflow, dose and solvent controls, and troubleshooting strategies for fungal infection research and antifungal resistance studies.

• Carbenoxolone disodium: Practical Lab Guide

  2026-09-28

  Carbenoxolone disodium is an 11β-hydroxysteroid dehydrogenase inhibitor for probing glucocorticoid access, corticosterone metabolism, and gap junction communication in controlled cell, tissue, or enzyme workflows. Use it with matched vehicle and orthogonal controls; the product information does not establish selective target validation or support treating it as an in vivo efficacy agent.

• Antiemetics Inhibit Renal OCT2 and MATE1 Transport

  2026-09-27

  George and colleagues tested five 5-HT3 antagonist antiemetics in complementary cell models and found that several inhibit OCT2- or MATE1-mediated organic-cation transport. Their results identify a potential mechanism for altered renal drug secretion, while emphasizing that transporter inhibition in vitro does not by itself establish a clinical drug interaction.

• Formononetin Protects Against Oxaliplatin Neuropathy

  2026-09-26

  The study identifies formononetin as a candidate for reducing oxaliplatin-related neuronal injury in a cell model, linking protection to lower oxidative stress, reduced apoptosis, and Nrf2/HO-1 pathway activation. It also reports that formononetin preserved oxaliplatin and paclitaxel activity in two cancer-cell models, whereas the antioxidant NAC diminished anticancer effects—an important distinction that remains to be tested beyond cells.

• AMPK–JAK2/STAT3 in Obesity-Related Asthma

  2026-09-25

  A study of obesity-related asthma links reduced AMPK expression and M1 macrophage polarization with airway inflammation, and identifies JAK2/STAT3 signaling as a pathway associated with the effects of AMPK activation. Its combined cell and mouse models offer a framework for investigating inflammation inhibition via AMPK activation, while leaving important questions about model specificity and clinical relevance open.

• Carvedilol Phosphate for Mechanistic IRI Studies

  2026-09-25

  Use Carvedilol Phosphate to probe adrenergic GPCR signaling alongside hepatocyte–macrophage interactions in ischemia–reperfusion experiments—not as an assumed treatment for liver injury. This workflow pairs careful compound handling with orthogonal Arrb2, macrophage-polarization, and 6-ketoLCA readouts.

• PYR-41 for E1 Ubiquitination Research

  2026-09-24

  Use PYR-41 to probe ubiquitin activation upstream of protein turnover and inflammatory signaling, with workflows for E1 engagement, NF-κB readouts, and immune-cell studies. Its broad effects make careful dose-ranging and orthogonal controls essential—especially when applying E1 inhibition to the distinct TRAF2–STING biology of tumor-associated B cells.

• Ertapenem: Applied Workflows for Resistance Research

  2026-09-24

  Use Ertapenem sodium salt to connect a reproducible carbapenem susceptibility readout with resistance-gene and transmission analyses. This workflow guide translates recent CREC findings into practical assay choices while emphasizing controls, interpretation limits, and compound handling.

• WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis

  2026-09-23

  The study identifies WNT5a–GSK3–β-catenin signaling as a regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). Its combined pharmacological, cellular, and transcriptomic evidence links pathway modulation to reduced fat infiltration and improved support for muscle satellite-cell differentiation in experimental models.

• EdU Imaging Kits (Cy3): From Signal to Biology

  2026-09-23

  EdU Imaging Kits (Cy3) reveal S-phase DNA synthesis without DNA denaturation. This article shows how to interpret EdU labeling mechanistically in CCR7/DUSP1-regulated fibroblast–tumor models, rather than treating proliferation as an isolated endpoint.

• Meropenem Trihydrate: Mechanism and Resistance Research

  2026-09-22

  Meropenem trihydrate is a broad-spectrum carbapenem antibiotic used to investigate bacterial cell-wall inhibition, antimicrobial susceptibility, and resistance phenotypes. LC-MS/MS evidence shows that metabolite patterns can distinguish carbapenemase-producing Enterobacterales from non-producing isolates in less than 7 hours, but those signatures do not independently prove the resistance mechanism.

8105 records 1/541 page Next 12345 下5页 Last page